نتائج البحث

1

دورية أكاديمية

Impact of prior treatment on selinexor, bortezomib, dexamethasone outcomes in patients with relapsed/refractory multiple myeloma: Extended follow‐up subgroup analysis of the BOSTON trial.

المؤلفون: Mateos, Maria‐Victoria, Engelhardt, Monika, Leleu, Xavier, Mesa, Mercedes Gironella, Cavo, Michele, Dimopoulos, Meletios, Bianco, Martina, Merlo, Giovanni Marino, Porte, Charles la, Richardson, Paul G., Moreau, Philippe

المصدر: European Journal of Haematology; Aug2024, Vol. 113 Issue 2, p242-252, 11p

مصطلحات موضوعية: MULTIPLE myeloma, BORTEZOMIB, CLINICAL trials, PROTEASOME inhibitors, SUBGROUP analysis (Experimental design)

مصطلحات جغرافية: BOSTON (Mass.)

2

دورية أكاديمية

Effect of prior treatments on selinexor, bortezomib, and dexamethasone in previously treated multiple myeloma

المساهمون: Mateos M.V., Gavriatopoulou M., Facon T., Auner H.W., Leleu X., Hajek R., Dimopoulos M.A., Delimpasi S., Simonova M., Spicka I., Pour L., Kriachok I., Pylypenko H., Doronin V., Usenko G., Benjamin R., Dolai T.K., Sinha D.K., Venner C.P., Garg M., Stevens D.A., Quach H., Jagannath S., Moreau P., Levy M., Badros A.Z., Anderson L.D., Bahlis N.J., Cavo M., Chai Y., Jeha J., Arazy M., Shah J., Shacham S., Kauffman M.G., Richardson P.G., Grosicki S.

مصطلحات موضوعية: Exportin-1, Multiple myeloma, Selinexor, SINE compound, Antineoplastic Combined Chemotherapy Protocol, Bortezomib, Dexamethasone, Female, Human, Hydrazine, Male, Triazoles

وصف الملف: STAMPA

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/33849608; info:eu-repo/semantics/altIdentifier/wos/WOS:000640253700001; volume:14; issue:1; firstpage:59; lastpage:59; numberofpages:1; journal:JOURNAL OF HEMATOLOGY & ONCOLOGY; http://hdl.handle.net/11585/865139Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85104307966; https://jhoonline.biomedcentral.com/articles/10.1186/s13045-021-01071-9Test

الإتاحة: https://doi.org/10.1186/s13045-021-01071-9Test
http://hdl.handle.net/11585/865139Test

View record in BASE

3

دورية أكاديمية

Effect of age and frailty on the efficacy and tolerability of once-weekly selinexor, bortezomib, and dexamethasone in previously treated multiple myeloma

المساهمون: Auner H.W., Gavriatopoulou M., Delimpasi S., Simonova M., Spicka I., Pour L., Dimopoulos M.A., Kriachok I., Pylypenko H., Leleu X., Doronin V., Usenko G., Hajek R., Benjamin R., Dolai T.K., Sinha D.K., Venner C.P., Garg M., Stevens D.A., Quach H., Jagannath S., Moreau P., Levy M., Badros A., Anderson L.D., Bahlis N.J., Facon T., Mateos M.V., Cavo M., Chai Y., Arazy M., Shah J., Shacham S., Kauffman M.G., Richardson P.G., Grosicki S.

وصف الملف: STAMPA

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/33755235; info:eu-repo/semantics/altIdentifier/wos/WOS:000646325700001; volume:96; issue:6; firstpage:708; lastpage:718; numberofpages:11; journal:AMERICAN JOURNAL OF HEMATOLOGY; https://hdl.handle.net/11585/865006Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85104358050

الإتاحة: https://doi.org/10.1002/ajh.26172Test
https://hdl.handle.net/11585/865006Test

View record in BASE

4

دورية أكاديمية

Selinexor, bortezomib, and dexamethasone versus bortezomib and dexamethasone in previously treated multiple myeloma: Outcomes by cytogenetic risk

المساهمون: Richard S., Chari A., Delimpasi S., Simonova M., Spicka I., Pour L., Kriachok I., Dimopoulos M.A., Pylypenko H., Auner H.W., Leleu X., Usenko G., Hajek R., Benjamin R., Dolai T.K., Sinha D.K., Venner C.P., Garg M., Stevens D.A., Quach H., Jagannath S., Moreau P., Levy M., Badros A., Anderson L.D., Bahlis N.J., Facon T., Mateos M.V., Cavo M., Chang H., Landesman Y., Chai Y., Arazy M., Shah J., Shacham S., Kauffman M.G., Grosicki S., Richardson P.G.

مصطلحات موضوعية: Adult, Aged, Antineoplastic Agent, Antineoplastic Combined Chemotherapy Protocol, Bortezomib, Cytogenetic Analysi, Dexamethasone, Female, Human, Hydrazine, Male, Middle Aged, Multiple Myeloma, Progression-Free Survival, Treatment Outcome, Triazole, Young Adult

وصف الملف: STAMPA

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/34062004; info:eu-repo/semantics/altIdentifier/wos/WOS:000669628300001; volume:96; issue:9; firstpage:1120; lastpage:1130; numberofpages:11; journal:AMERICAN JOURNAL OF HEMATOLOGY; https://hdl.handle.net/11585/865100Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85109074071

الإتاحة: https://doi.org/10.1002/ajh.26261Test
https://hdl.handle.net/11585/865100Test

View record in BASE

5

دورية أكاديمية

Daratumumab Plus Bortezomib, Melphalan, and Prednisone Versus Bortezomib, Melphalan, and Prednisone in Transplant-Ineligible Newly Diagnosed Multiple Myeloma: Frailty Subgroup Analysis of ALCYONE

المؤلفون: Mateos M. -V., Dimopoulos M. A., Cavo M., Suzuki K., Knop S., Doyen C., Lucio P., Nagy Z., Pour L., Grosicki S., Crepaldi A., Liberati A. M., Campbell P., Yoon S. -S., Iosava G., Fujisaki T., Garg M., Iida S., Blade J., Ukropec J., Pei H., Van Rampelbergh R., Kudva A., Qi M., San-Miguel J.

المساهمون: Mateos M.-V., Dimopoulos M.A., Cavo M., Suzuki K., Knop S., Doyen C., Lucio P., Nagy Z., Pour L., Grosicki S., Crepaldi A., Liberati A.M., Campbell P., Yoon S.-S., Iosava G., Fujisaki T., Garg M., Iida S., Blade J., Ukropec J., Pei H., Van Rampelbergh R., Kudva A., Qi M., San-Miguel J.

مصطلحات موضوعية: CD38, Clinical study, Efficacy, Frail, Monoclonal antibody, Aged, 80 and over, Antibodies, Monoclonal, Antineoplastic Combined Chemotherapy Protocol, Bortezomib, Female, Human, Male, Melphalan, Multiple Myeloma, Prednisone

وصف الملف: STAMPA

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/34344638; info:eu-repo/semantics/altIdentifier/wos/WOS:000713462500021; volume:21; issue:11; firstpage:785; lastpage:798; numberofpages:14; journal:CLINICAL LYMPHOMA MYELOMA & LEUKEMIA; https://hdl.handle.net/11585/864152Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85111556972; https://www.clinical-lymphoma-myeloma-leukemia.com/article/S2152-2650Test(21)00210-X

الإتاحة: https://doi.org/10.1016/j.clml.2021.06.005Test
https://hdl.handle.net/11585/864152Test
https://www.clinical-lymphoma-myeloma-leukemia.com/article/S2152-2650Test(21)00210-X

View record in BASE

6

دورية أكاديمية

Minimal residual disease assessment by multiparameter flow cytometry in transplant-eligible myeloma in the EMN02/HOVON 95 MM trial

المؤلفون: Oliva S., Bruinink D. H., Rihova L., D'Agostino M., Pantani L., Capra A., van der Holt B., Troia R., Petrucci M. T., Villanova T., Vsianska P., Jugooa R., Brandt-Hagens C., Gilestro M., Offidani M., Ribolla R., Galli M., Hajek R., Gay F., Cavo M., Omede P., van der Velden V. H. J., Boccadoro M., Sonneveld P.

المساهمون: Oliva S., Bruinink D.H., Rihova L., D'Agostino M., Pantani L., Capra A., van der Holt B., Troia R., Petrucci M.T., Villanova T., Vsianska P., Jugooa R., Brandt-Hagens C., Gilestro M., Offidani M., Ribolla R., Galli M., Hajek R., Gay F., Cavo M., Omede P., van der Velden V.H.J., Boccadoro M., Sonneveld P.

مصطلحات موضوعية: Antineoplastic Combined Chemotherapy Protocol, Autograft, Bone Marrow Cell, Bortezomib, Dexamethasone, Disease-Free Survival, Female, Human, Lenalidomide, Male, Melphalan, Middle Aged, Neoplasm, Residual, Survival Rate, Flow Cytometry, Hematopoietic Stem Cell Transplantation, Multiple Myeloma

وصف الملف: STAMPA

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/34083504; info:eu-repo/semantics/altIdentifier/wos/WOS:000657729400001; volume:11; issue:6; firstpage:1; lastpage:9; numberofpages:9; journal:BLOOD CANCER JOURNAL; http://hdl.handle.net/11585/865103Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85107145070; https://www.nature.com/articles/s41408-021-00498-0Test

الإتاحة: https://doi.org/10.1038/s41408-021-00498-0Test
http://hdl.handle.net/11585/865103Test
https://www.nature.com/articles/s41408-021-00498-0Test

View record in BASE

7

دورية أكاديمية

المؤلفون: Knop S., Mateos M. -V., Dimopoulos M. A., Suzuki K., Jakubowiak A., Doyen C., Lucio P., Nagy Z., Usenko G., Pour L., Cook M., Grosicki S., Crepaldi A., Liberati A. M., Campbell P., Shelekhova T., Yoon S. -S., Losava G., Fujisaki T., Garg M., Wang J., Wroblewski S., Kudva A., Gries K. S., Fastenau J., San-Miguel J., Cavo M.

المساهمون: Knop S., Mateos M.-V., Dimopoulos M.A., Suzuki K., Jakubowiak A., Doyen C., Lucio P., Nagy Z., Usenko G., Pour L., Cook M., Grosicki S., Crepaldi A., Liberati A.M., Campbell P., Shelekhova T., Yoon S.-S., Losava G., Fujisaki T., Garg M., Wang J., Wroblewski S., Kudva A., Gries K.S., Fastenau J., San-Miguel J., Cavo M.

مصطلحات موضوعية: Aged, Antibodies, Monoclonal, Antineoplastic Combined Chemotherapy Protocol, Bortezomib, Disease Progression, Drug Administration Schedule, Female, Human, Male, Melphalan, Middle Aged, Multiple Myeloma, Prednisone, Treatment Outcome, Patient Reported Outcome Measure, Quality of Life

وصف الملف: STAMPA

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/34078314; info:eu-repo/semantics/altIdentifier/wos/WOS:000660623100005; volume:21; issue:1; firstpage:659; lastpage:659; numberofpages:1; journal:BMC CANCER; http://hdl.handle.net/11585/867411Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85107143398; https://bmccancer.biomedcentral.com/articles/10.1186/s12885-021-08325-2Test

الإتاحة: https://doi.org/10.1186/s12885-021-08325-2Test
http://hdl.handle.net/11585/867411Test

View record in BASE

8

دورية أكاديمية

Overall survival with daratumumab, bortezomib, melphalan, and prednisone in newly diagnosed multiple myeloma (ALCYONE): a randomised, open-label, phase 3 trial.

المصدر: Lancet, Vol. 395, no. 10218, p. 132-141 (2020)

مصطلحات موضوعية: Adult, Aged, 80 and over, Antibodies, Monoclonal, Asia, Bortezomib, Disease-Free Survival, Drug Administration Schedule, Drug Therapy, Combination, Europe, Female, Humans, Maintenance Chemotherapy, Male, Melphalan, Middle Aged, Multiple Myeloma, North America, Prednisone, South America, Survival Analysis, Treatment Outcome

العلاقة: boreal:226818; http://hdl.handle.net/2078.1/226818Test; info:pmid/31836199; urn:ISSN:0140-6736; urn:EISSN:1474-547X

الإتاحة: https://doi.org/10.1016/S0140-6736Test(19)32956-3
http://hdl.handle.net/2078.1/226818Test

View record in BASE

9

دورية أكاديمية

Daratumumab plus bortezomib, melphalan, and prednisone for untreated myeloma

المؤلفون: Mateos, M. -V., Dimopoulos, M. A., Cavo, M., Suzuki, K., Jakubowiak, A., Knop, S., Doyen, C., Lucio, P., Nagy, Z., Kaplan, P., Pour, L., Cook, M., Grosicki, S., Crepaldi, A., Liberati, A. M., Campbell, P., Shelekhova, T., Yoon, S. -S., Iosava, G., Fujisaki, T., Garg, M., Chiu, C., Wang, J., Carson, R., Crist, W., Deraedt, W., Nguyen, H., Qi, M., San-Miguel J., Foa R.

المساهمون: Mateos, M. -V., Dimopoulos, M. A., Cavo, M., Suzuki, K., Jakubowiak, A., Knop, S., Doyen, C., Lucio, P., Nagy, Z., Kaplan, P., Pour, L., Cook, M., Grosicki, S., Crepaldi, A., Liberati, A. M., Campbell, P., Shelekhova, T., Yoon, S. -S., Iosava, G., Fujisaki, T., Garg, M., Chiu, C., Wang, J., Carson, R., Crist, W., Deraedt, W., Nguyen, H., Qi, M., San-Miguel, J., Foa, R.

مصطلحات موضوعية: Adult, Aged, Antibodies, Monoclonal, Antineoplastic Combined Chemotherapy Protocol, Bortezomib, Disease-Free Survival, Female, Follow-Up Studie, Human, Infection, Intention to Treat Analysi, Kaplan-Meier Estimate, Male, Melphalan, Middle Aged, Multiple Myeloma, Prednisone, Survival Rate, Medicine (all)

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/29231133; info:eu-repo/semantics/altIdentifier/wos/WOS:000424335200007; volume:378; issue:6; firstpage:518; lastpage:528; numberofpages:11; journal:NEW ENGLAND JOURNAL OF MEDICINE; http://hdl.handle.net/11573/1085850Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85042083059; http://www.nejm.org/medical-indexTest

الإتاحة: https://doi.org/10.1056/NEJMoa1714678Test
http://hdl.handle.net/11573/1085850Test
http://www.nejm.org/medical-indexTest

View record in BASE

10

دورية أكاديمية

Multiple Myeloma Treatment in Real-world Clinical Practice: Results of a Prospective, Multinational, Noninterventional Study

المؤلفون: Mohty M., Terpos E., Mateos M. -V., Cavo M., Lejniece S., Beksac M., Bekadja M. A., Legiec W., Dimopoulos M., Stankovic S., Duran M. S., De Stefano V., Corso A., Kochkareva Y., Laane E., Berthou C., Salwender H., Masliak Z., Peceliunas V., Willenbacher W., Silva J., Louw V., Nemet D., Borbenyi Z., Abadi U., Pedersen R. S., Cernelc P., Potamianou A., Couturier C., Feys C., Thoret-Bauchet F., Boccadoro M., Bekadja M., Hamladji R. -M., Ali H. A., Hamdi S., Touhami H., Mansour N. S., Linkesch W., Abildgaard N., Hein M., Eveillard J. R., Yamani A. E., Moreau P., Sanhes L., Lepeu G., Laribi K., Jourdan E., Fitoussi O., Allangba O., Fleury J., Escoffre M., Benramdane R., Cartron G., Dine G., Legouffe E., Harich H. -D., Illmer T., Dorfel S., Hannig C. V., Koenigsmann M., Prange-Krex G., Tamm I., Zeller W., Maasberg M., Schlag R., Klausmann M., Uhlig J., Alkemper B., Schutz S., Tessen H. -W., Mohr B., Schmidt P., Heinrich B., Hebart H., Seipelt G., Zoeller T., Heits F., Muller-Naendrup C., Hansen R., Repp R., Von Weikersthal L. F., Schmits R., Hessling J., Krammer-Steiner B., Janzen V., Schauer M., Gruner M. W., Kisro J., Denzlinger C., Freier W., Junghanss C., Gorner M., Laichinger K., Ostermann H., Durk H., Hess G., Reich G., Matsouka P., Pouli A., Anagnostopoulos A., Masszi T., Ivanyi J., Szomor A., Nagler A., Magen H., Avivi I., Quitt M., Palumbo A., Za T., Vallisa D., Foa R., Bosi A., Vacca A., Lanza F., Palazzo G., Avvisati G., Ferrara F., Consoli U., Cantonetti M., Angelucci E., Califano C., Di Raimondo F., Guarini A., Musso M., Pizzuti M., Giuliani N., Ardizzoia A., Di Renzo N., Gaidano G., Gozzetti A., Pitini V., Farina G., Centurioni R., De Fabritiis P., Iuliano F., La Nasa G., La Verde G., Pane F., Recine U., La Targia M., Mineo G., Cangialosi C., Fagnani D., Federici A., Romano A., Specchia G., Storti S., Bongarzoni V., Bacigalupo A., Gobbi M., Latte G., Mannina D., Capalbo S., Jurgutis M., Woszczyk D., Holojda J., Gornik S., Pluta A., Morawiec-Szymonik E., Kyrcz-Krzemien S., Homenda W., Grosicki S., Sulek K., Lange A., Kloczko J., Starzak-Gwozdz J., Hellmann A., Komarnicki M., Kuliczkowski K., Viveiros C., Goncalves C., Esefyeva N., Kaplanov K., Volodicheva E., Laricheva E., Dergacheva V., Chukavina M., Volchenko N., Nazarova I., Anchukova L., Ovanesova E., Salogub G., Magomedova L., Kuznetsova I., Osyunikhina S., Serdyuk O., Karyagina E., Ivanova V., Cernelc S. P., Coetzee C., Gunther K., Moodley D., Duran S., Gutierrez A. E., De Oteyza J. P., Capote F. J., Casanova M., Sanchez J. M., Rios-Herranz E., Ibanez-Garcia J., Herranz M. J., Hernandez B., Sanchez S. S., Escalante F., Carnicero F., Lleonart J. B., Gironella M., Martinez R., De La Guia A. L., Palomera L., Iglesias R., Ramos F. S., De La Serna J., Sanchez P. G., Vidal J. B., Morfa M. D., Beksac T. -M., Vural F., Aydin Y., Unal A., Goker H., Bilgir O., Guvenc B., Turgut M., Ozet G. G., Ali R., Kyselyova M., Glushko N., Vybyrana R., Skrypnyk I., Tretyak N., Kharchevska T., Dyagil I., Popovs'ka T., Shimanskiy V., Lysa T., Oliynyk H., Vilchevskaya K., Kryachok I., Popovych Y., Romanyuk N., Yushchenko N., Kaplan P., Rekhtman G., Pylypenko H., Kozlov V., Drach J., Harousseau J. -L., Einsele H., Goldschmidt H., Facon T., Michalet M., Savchenko V. G., De la Rubia J., Cook G., Mellqvist U. -H., Ludwig H.

المساهمون: Mohty, M., Terpos, E., Mateos, M. -V., Cavo, M., Lejniece, S., Beksac, M., Bekadja, M. A., Legiec, W., Dimopoulos, M., Stankovic, S., Duran, M. S., De Stefano, V., Corso, A., Kochkareva, Y., Laane, E., Berthou, C., Salwender, H., Masliak, Z., Peceliunas, V., Willenbacher, W., Silva, J., Louw, V., Nemet, D., Borbenyi, Z., Abadi, U., Pedersen, R. S., Cernelc, P., Potamianou, A., Couturier, C., Feys, C., Thoret-Bauchet, F., Boccadoro, M., Bekadja, M., Hamladji, R. -M., Ali, H. A., Hamdi, S., Touhami, H., Mansour, N. S., Linkesch, W., Abildgaard, N., Hein, M., Eveillard, J. R., Yamani, A. E., Moreau, P., Sanhes, L., Lepeu, G., Laribi, K., Jourdan, E., Fitoussi, O., Allangba, O., Fleury, J., Escoffre, M., Benramdane, R., Cartron, G., Dine, G., Legouffe, E., Harich, H. -D., Illmer, T., Dorfel, S., Hannig, C. V., Koenigsmann, M., Prange-Krex, G., Tamm, I., Zeller, W., Maasberg, M., Schlag, R., Klausmann, M., Uhlig, J., Alkemper, B., Schutz, S., Tessen, H. -W., Mohr, B., Schmidt, P., Heinrich, B., Hebart, H., Seipelt, G., Zoeller, T., Heits, F., Muller-Naendrup, C., Hansen, R., Repp, R., Von Weikersthal, L. F., Schmits, R., Hessling, J., Krammer-Steiner, B., Janzen, V., Schauer, M., Gruner, M. W., Kisro, J., Denzlinger, C., Freier, W., Junghanss, C., Gorner, M., Laichinger, K., Ostermann, H., Durk, H., Hess, G., Reich, G., Matsouka, P., Pouli, A.

وصف الملف: ELETTRONICO

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/30030033; info:eu-repo/semantics/altIdentifier/wos/WOS:000448262300004; volume:18; issue:10; firstpage:e401; lastpage:e419; numberofpages:9; journal:CLINICAL LYMPHOMA MYELOMA & LEUKEMIA; http://hdl.handle.net/11392/2416062Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85050152150; https://www.sciencedirect.com/science/article/pii/S2152265018302301Test; https://www.clinical-lymphoma-myeloma-leukemia.com/action/showPdf?pii=S2152-2650Test(18)30230-1

الإتاحة: https://doi.org/10.1016/j.clml.2018.06.018Test
http://hdl.handle.net/11392/2416062Test
https://www.sciencedirect.com/science/article/pii/S2152265018302301Test
https://www.clinical-lymphoma-myeloma-leukemia.com/action/showPdf?pii=S2152-2650Test(18)30230-1

View record in BASE

تنقيح النتائج